These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8447165)

  • 1. Identification of a 33 kDa antigen associated with an adhesive and colonizing strain of Vibrio cholerae El Tor and its role in protection.
    Jacob A; Sinha VB; Sahib MK; Srivastava R; Kaper JB; Srivastava BS
    Vaccine; 1993; 11(3):376-82. PubMed ID: 8447165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the flagellar antigens of Vibrio cholerae El Tor and their role in protection.
    Sinha VB; Jacob A; Srivastava R; Kaper JB; Srivastava BS
    Vaccine; 1993; 11(3):372-5. PubMed ID: 8447164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection and immunity to Vibrio cholerae, Salmonella typhimurium and Escherichia coli in a rabbit model.
    Guinée PA; Jansen WH; Rijpkema SG
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):260-9. PubMed ID: 2464884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin.
    Fontana MR; Monaci E; Yanqing L; Guoming Q; Duan G; Rappuoli R; Pizza M
    Vaccine; 2000 Aug; 19(1):75-85. PubMed ID: 10924789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of biodegradable liposomes and microspheres as carriers for delivery of Vibrio cholerae antigens in the intestine.
    Chandrasekhar U; Sinha S; Bhagat HR; Sinha VB; Srivastava BS
    Vaccine; 1994 Nov; 12(15):1384-8. PubMed ID: 7887015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
    Kundu J; Mazumder R; Srivastava R; Srivastava BS
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 53 kDa protein of Vibrio cholerae classical strain 0395 involved in intestinal colonization.
    Singh SN; Srivastava R; Sinha VB; Srivastava BS
    Microb Pathog; 1994 Aug; 17(2):69-78. PubMed ID: 7861958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of TcpF-A2-CTB chimera and evidence of additive protective efficacy of immunizing with TcpF and CTB in the suckling mouse model of cholera.
    Price GA; Holmes RK
    PLoS One; 2012; 7(8):e42434. PubMed ID: 22879984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to outer membrane proteins of Vibrio cholerae induce protection by inhibition of intestinal colonization of vibrios.
    Sengupta DK; Sengupta TK; Ghose AC
    FEMS Microbiol Immunol; 1992 Jul; 4(5):261-6. PubMed ID: 1515155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of TnphoA mutants of Vibrio cholerae O139 for identification of antigens involved in colonisation.
    Bondre VP; Srivastava R; Sinha VB; Srivastava BS
    J Med Microbiol; 1997 Dec; 46(12):1007-11. PubMed ID: 9402922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
    García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
    Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains.
    Benítez JA; Silva AJ; Rodríguez BL; Fando R; Campos J; Robert A; García H; García L; Pérez JL; Oliva R; Torres CA; Ledón T
    Arch Med Res; 1996; 27(3):275-83. PubMed ID: 8854382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of chitosan nanoparticles containing CtxB antigen against Vibrio cholera.
    Tabrizi NM; Amani J; Ebrahimzadeh M; Nazarian S; Kazemi R; Almasian P
    Microb Pathog; 2018 Nov; 124():170-177. PubMed ID: 30138759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of hemagglutinin/protease and motility to the pathogenesis of El Tor biotype cholera.
    Silva AJ; Leitch GJ; Camilli A; Benitez JA
    Infect Immun; 2006 Apr; 74(4):2072-9. PubMed ID: 16552036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of a non-adhesive mutant of Vibrio cholerae and chromosomal localization of the gene controlling mannose-sensitive adherence.
    Srivastava R; Srivastava BS
    J Gen Microbiol; 1980 Mar; 117(1):275-8. PubMed ID: 7391820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of some antigenically related outer-membrane proteins of strains of Vibrio cholerae O1 and non-O1 serovars involved in intestinal adhesion and the protective role of antibodies to them.
    Sengupta D; Datta-Roy K; Banerjee K; Ghose AC
    J Med Microbiol; 1989 May; 29(1):33-9. PubMed ID: 2724325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraduodenal inoculation of adult rabbits for evaluating the immunogenicity of genetically attenuated Vibrio cholerae strains.
    García Imia L; Oliva Hernández R; Cedré Marrero B; Valmaseda Pérez T; García Sánchez H; Talavera Coronel A; Pérez Quiñoy JL; Sierra González G
    Lab Anim Sci; 1998 Oct; 48(5):538-41. PubMed ID: 10090073
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits.
    Eko FO; Schukovskaya T; Lotzmanova EY; Firstova VV; Emalyanova NV; Klueva SN; Kravtzov AL; Livanova LF; Kutyrev VV; Igietseme JU; Lubitz W
    Vaccine; 2003 Sep; 21(25-26):3663-74. PubMed ID: 12922096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.